New York, NY , 02/17/2021 / Wisebitcoin /
Crypto exchange veteran, investor, and entrepreneur Andrew Chae has become another addition to the Wisebitcoin decentralized exchange’s team. Following a recent announcement by colleague Sangwook Lee, he joins the company as a senior advisor as well. Both have seen potential in the cryptocurrency exchange to develop services for professional traders that are unparalleled in the industry.
Mr. Chae is the former CSO of Huobi Korea, a leading exchange in the Asian cryptocurrency markets, and Bluehelix Korea Co-CEO, a pioneering blockchain technology provider. Andrew Chae’s participation in Wisebitcoin is sure to bring key insights into building better tools and customer service, both of which are features that distinguish Wisebitcoin among its competitors. The new senior advisor is also known for founding the Korea-China Leaders Forum.
“I’m happy to join Wisebitcoin as an advisor and I’m excited to contribute in optimizing Wisebitcoin’s ability to provide the public with a safe but easy exchange environment,” said Mr. Chae.
Wisebitcoin recently launched special trading features such as the unique ability to place long and short positions with leverage of up to 100:1 for contract trading to over 15 million users and 280 merchants around the globe. The exchange also offers deep liquidity and around-the-clock customer service.
About Wisebitcoin
Wisebitcoin is a global decentralized exchange for professional traders with a multicultural team of over 50 specialists. The platform provides unparalleled services such as 24/7 live phone support, cloud infrastructure, an affiliate program, and deep liquidity. Other important features include a user-friendly interface, a mobile app, and an insurance fund for asset protection.
To learn more visit www.wisebitcoin.com or https://twitter.com/wisebitcoin.
Media contact:
Robert Penington
Robert@thronepr.com
Source: Story.KISSPR.com
Release ID: 16960
Disclaimer: The information does not constitute advice or an offer to buy. Any purchase made from this story is made at your own risk. Consult an expert advisor/health professional before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website’s selling. The content publisher and its distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about.
